IGC IGC Pharma
- 0.4114
- -0.0021-0.51%
IGC Pharma News
IGC Pharma to Participate in Fireside Chat With Ascendiant Capital Markets
Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
Anson Funds agreed to a $2.25 million settlement with the Securities and Exchange Commission (SEC) over a secret relationship with a short seller affecting two cannabis companies. The SEC found that w
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersViracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Purple Biotech (NASDAQ:PPBT) stock in
Express News | IGC Pharma Publishes Study In European Society Of Medicine For Impact Of CYP2C9 Genetic Polymorphism On Pharmacokinetics Of Delta 9 Tetrahydrocannabinol
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLiquidia (NASDAQ:LQDA) stock rose 12.7% to $14.5 during Friday's after-market session. The market value of their outstanding shares is at $1.1 billion. Adagene (NASDAQ:ADAG) shares moved upward
Express News | IGC Pharma Announces Patient Enrollment At Neurostudies For Its Phase 2 Trial Of IGC-AD1 In Alzheimer's
Express News | IGC Pharma Inc -Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Express News | IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
IGC Pharma to Attend BIO International Convention 2024
IGC Pharma, Inc (NYSE:IGC) ("IGC" or the "Company"), today announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6,
Express News | 'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment
6.7 Million Americans Live With Alzheimer's - IGC Pharma Believes They Deserve Treatment Options...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent And Established Law And Regulations (Two Confidential...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent An
Express News | 'Declassifying Cannabis Still Leaves Pot Stocks In Limbo' - Wall Street Journal
Express News | Shares of Cannabis-related Stocks Are Trading Higher Following Reports Suggesting the DEA Plans to Reclassify Cannabis as a Less Dangerous Drug
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. NanoVibronix (NASDAQ:NAOV) shares moved upwar
Express News | Shares of Cannabis Stocks Are Trading Higher Following a Report Indicating the DEA Is Moving to Reclassify Marijuana as a Less Dangerous Drug
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
Express News | Watching Shares Of Marijuana Stocks; Traders Circulate Comments From The TDR Podcast Saying "We've Heard Rumors That Potentially That Announcement Could Be Coming This Week - Whatever The Decision May Be", "I'm Hearing From Some Sources That Pro-Marijuana
Express News | IGC Pharma Announces Interim Results For IGC-AD1 In Reducing Alzheimer's Agitation; Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared To Placebo
Express News | IGC Pharma Inc- Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared to Placebo
Analysis
Price Target
No Data
